1. American Cancer Society. Cancer Facts and Figures. 1977. Atlanta, GA:
2. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ. Cancer statistics 2006. CA Cancer J Clin. 2006. 56:106–130.
Article
3. Cho JH. Radiation Treatment for Prostate Cancer. J Korean Med Assoc. 2004. 47:424–431.
Article
4. Stone NN, Stock RG. Long-term urinary, sexual, and rectal morbidity in patients treated with iodine-125 prostate brachytherapy followed up for a minimum of 5 years. Urology. 2007. 69:338–342.
Article
5. Oh MM, Bahk YW, Tropper SE. Preliminary Report of Clinical Experience of Iodine-125 Seed Implant for Early Prostatic Cancer: The First Case in Korea. Korean J Urol. 2001. 42:1235–1240.
6. Buron C, Le Vu B, Cosset JM, Pommier P, Peiffert D, Delannes M, Flam T, Guerif S, Salem N, Chauveinc L, Livartowski A. Brachytherapy versus prostatectomy in localized prostate cancer: results of a French multicenter prospective medico-economic study. Int J Radiat Oncol Biol Phys. 2007. 67:812–822.
Article
7. Holm HH, Juul N, Pedersen JF, Hansen H, Strøyer I. Transperineal 125iodine seed implantation in prostatic cancer guided by transrectal ultrasonography. J Urol. 1983. 130:283–286.
8. Xue J, Waterman F, Handler J, Gressen E. Localization of linked 125I seeds in postimplant TRUS images for prostate brachytherapy dosimetry. Int J Radiat Oncol Biol Phys. 2005. 62:912–919.
Article
9. Horwitz EM, Mitra RK, Uzzo RG, Das IJ, Pinover WH, Hanlon AL, McNeeley SW, Hanks GE. Impact of target volume coverage with Radiation Therapy Oncology Group (RTOG) 98-05 guidelines for transrectal ultrasound guided permanent Iodine-125 prostate implants. Radiother Oncol. 2003. 66:173–179.
Article
10. Koutrouvelis PG. Three-dimensional stereotactic posterior ischiorectal space computerized tomography guided brachytherapy of prostate cancer: a preliminary report. J Urol. 1998. 159:142–145.
11. Tanaka O, Hayashi S, Kanematsu M, Matsuo M, Nakano M, Maeda S, Deguchi T, Hoshi H. CT-based postimplant dosimetry of prostate brachytherapy: comparison of 1-mm and 5-mm section CT. Radiat Med. 2007. 25:22–26.
Article
12. Moerland MA, Wijrdeman HK, Beersma R, Bakker CJ, Battermann JJ. Evaluation of permanent I-125 prostate implants using radiography and magnetic resonance imaging. Int J Radiat Oncol Biol Phys. 1997. 37:927–933.
Article
13. Dubois DF, Prestidge BR, Hotchkiss LA, Bice WS Jr, Prete JJ. Source localization following permanent transperineal prostate interstitial brachytherapy using magnetic resonance imaging. Int J Radiat Oncol Biol Phys. 1997. 39:1037–1041.
Article
14. Amols HI, Rosen II. A three-film technique for reconstruction of radioactive seed implants. Med Phys. 1981. 8:210–214.
Article
15. Haworth A, Ebert M, St Clair S, Carey BM, Flynn A, Bottomley DM, Duchesne GM, Joseph D, Ash D. Impact of selection of post-implant technique on dosimetry parameters for permanent prostate implants. Brachytherapy. 2005. 4:146–153.
Article
16. Crook J, McLean M, Yeung I, Williams T, Lockwood G. MRI-CT fusion to assess postbrachytherapy prostate volume and the effects of prolonged edema on dosimetry following transperineal interstitial permanent prostate brachytherapy. Brachytherapy. 2004. 3:55–60.
Article
17. Roy JN, Wallner KE, Harrington PJ, Ling CC, Anderson LL. A CT-based evaluation method for permanent implants: application to prostate. Int J Radiat Oncol Biol Phys. 1993. 26:163–169.
Article
18. Brinkmann DH, Kline RW. Automated seed localization from CT datasets of the prostate. Med Phys. 1998. 25:1667–1672.
Article
19. Roach M 3rd, Faillace-Akazawa P, Malfatti C, Holland J, Hricak H. Prostate volumes defined by magnetic resonance imaging and computerized tomographic scans for three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys. 1996. 35:1011–1018.
Article
20. Smith WL, Lewis C, Bauman G, Rodrigues G, D'Souza D, Ash R, Ho D, Venkatesan V, Downey D, Fenster A. Prostate volume contouring: a 3D analysis of segmentation using 3DTRUS, CT, and MR. Int J Radiat Oncol Biol Phys. 2007. 67:1238–1247.
Article